Premium
Neutral sphingomyelinase 3 modulates myotube density and is regulated by microRNA‐133
Author(s) -
Wolf Erin M.,
McCarthy John J.,
Moylan Jennifer S.,
Smith Jeffrey D.,
Reid Michael B.
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.737.4
Subject(s) - c2c12 , myogenesis , sphingomyelin , ceramide , transfection , microrna , three prime untranslated region , microbiology and biotechnology , luciferase , sphingolipid , reporter gene , biology , myocyte , chemistry , untranslated region , messenger rna , gene expression , gene , biochemistry , apoptosis , membrane
The neutral sphingomyelinase (nSMase) family is a group of enzymes that catalyzes the conversion of sphingomyelin to ceramide in a pH dependent manner. Sphingomyelinase activity and sphingolipid signaling play a role in the regulation of cellular processes. Our current data suggest that a novel, muscle‐specific neutral sphingomyelinase, nSMase3, may regulate muscle cell size. Overexpression of nSMase3 in C2C12 myotubes causes a decrease in myotube density, while treatment with an nSMase3 siRNA causes an increase in myotube density. MicroRNA‐133 (miR‐133) is a muscle‐specific small RNA molecule that has roles in proliferation and differentiation of myoblasts. A sequence within the 3′ untranslated region (UTR) of nSMase3 contains a predicted miR‐133 binding site. We hypothesize that miR‐133 inhibits nSMase3 translation and therefore plays a role in its regulation of cell size. In support of our hypothesis, expression of miR‐133 progressively increased while nSMase3 protein levels decreased during myotube differentiation. To test our hypothesis, a luciferase reporter gene containing the 3′ UTR of nSMase3 was cloned and used in a transient transfection assay. Co‐transfection of the reporter gene and miR‐133 decreased luciferase activity. These data suggest that miR‐133 is capable of regulating the expression of nSMase3 and, thus, may have a role in the regulation of muscle size.